Position in IXHL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$5,784
New position
Shares Held
1,928
first reported quarter
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 20 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Quent Capital, LLC holds $2,626,931 across 11 Drug Manufacturers - Specialty & Generic names. IXHL ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,123 | $2,444,856 | |
| 2 | ZTS |
Zoetis Inc.
|
436 | $51,539 | |
| 3 | VTRS |
Viatris Inc
|
3,229 | $43,623 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
188 | $24,767 | |
| 5 | ALKS |
Alkermes plc.
|
678 | $23,974 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
491 | $10,193 | |
| 7 | INCR |
Intercure Ltd.
|
10,321 | $7,751 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
299 | $7,155 |
All Filings in IXHL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,784 | 1,928 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||